Fürth, May 7, 2024 – HMG Systems Engineering announces the transfer of its innovation in the field of pharmacogenetics to a new company: PGXperts GmbH. This spin-off marks an important milestone after nine years of research and development in the field of personalized medication, which was rewarded with high customer acceptance in 2023.
The global demand for digital solutions for personalized medication, taking pharmacogenetics into account, has risen sharply in recent years. The spin-off of the business unit is an important step towards meeting this demand and making the benefits of personalized medication accessible to all patients in the future with the help of PGXperts.
HMG Systems Engineering will continue to offer its core business, engineering services for the digital transformation in the areas of e-health, mobility and renewable energies.
